Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

C1q antibody

The Goat Polyclonal anti-C1q antibody (ABIN636141) specifically detects C1q. The antibody is reactive with Human samples.
Catalog No. ABIN636141
$1,146.68
Plus shipping costs $50.00
1 mg
Shipping to: United States
Delivery in 9 to 12 Business Days

Quick Overview for C1q antibody (ABIN636141)

Target

See all C1q Antibodies
C1q (Complement Fragment C1q (C1q))

Reactivity

  • 29
  • 15
  • 2
Human

Host

  • 15
  • 15
  • 5
  • 4
  • 4
  • 1
Goat

Clonality

  • 22
  • 21
Polyclonal

Conjugate

  • 24
  • 10
  • 7
  • 1
  • 1
  • 1
This C1q antibody is un-conjugated

Application

Please inquire
  • Specificity

    Complement C1 q antibody was raised against Human Complement C1 .

    Purification

    Affinity purified

    Purity

    > 95 % pure

    Sterility

    Filtered

    Immunogen

    Human Complement C1 q
    Goat serum was obtained from healthy animals of US origin and under the care of a registered veterinarian.
  • Application Notes

    Optimal conditions should be determined byt he investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Clear, colorless liquid, 0.2 µm filtered, containing 10 mM Sodium Phosphate, 0.15 M Sodium Chloride and 0.05 % (w/v) Sodium Azide. Protease/IgG free.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store at 2-8 °C.
  • Target

    C1q (Complement Fragment C1q (C1q))

    Alternative Name

    Complement C1q

    Background

    The C1q complex is potentially multivalent for attachment to the complement fixation sites of immunoglobulin. The sites are on the CH2 domain of IgG and, it is thought, on the CH4 domain of IgM. The appropriate peptide sequence of the complement fixing site might become exposed following complexing of the immunoglobulin, or the sites might always be available, but might require multiple attachment by C1q with critical geometry in order to achieve the necessary avidity.
You are here:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!